SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-22-104684
Filing Date
2022-04-14
Accepted
2022-04-13 21:51:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC TO-C d339898dsctoc.htm SC TO-C 27105
2 EX-99.(A)(5)(G) d339898dex99a5g.htm EX-99.(A)(5)(G) 98030
3 GRAPHIC g337959dsp1.jpg GRAPHIC 2696
  Complete submission text file 0001193125-22-104684.txt   131082
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Subject) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-47575 | Film No.: 22825867
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filed by) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2836 Biological Products, (No Diagnostic Substances)